Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...
A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...
Since 2023, Abiraterone has been provided free on the NHS in Scotland and Wales, leaving men in England having to pay ...
Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.
Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...
University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
This week, more information has become available about state funding in Iowa following Governor Reynolds' announcement of ...
September is Prostate Cancer Awareness Month, and health leaders are reminding men that early detection is the key to living ...
News-Medical.Net on MSN
PSA-based tool improves decision making for prostate cancer screening and treatment
In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...
Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...
News-Medical.Net on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results